Sharechat Logo

Housing NZ chair Jackson quits over potential conflict with Fletcher directorship

Thursday 6th June 2013

Text too small?

Housing New Zealand chairman Alan Jackson has handed in his resignation over the potential for a conflict of interest with his directorship with construction firm Fletcher Building.

Housing Minister Nick Smith said he has accepted the resignation to let Jackson avoid the conflict, given the possibility Fletcher may tender for Housing NZ's rebuilding programme in Christchurch.

Jackson is giving up $49,500 a year in director's fees at Housing NZ, and keeping the $173,250 he gets at Fletcher, where he chairs its remuneration committee. He joined the Housing NZ board in December 2010, and has been a director at Fletcher since 2009.

"I am disappointed to be losing his skills but support his decision given the potential conflict of interest," Smith said in a statement.

Last week the minister unveiled a $170 million project to replace 700 earthquake-damaged Housing NZ properties in Christchurch.

Jackson has already lost one government-appointed role over the potential for conflicts of interest. The High Court overturned Racing Minister Nathan Guy's decision to appoint him as an independent chair of the New Zealand Racing Board due to Jackson's connections to the thoroughbred industry.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors